-
Sector Analysis
NewComputed Tomography (CT) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Computed Tomography (CT) Systems Market Report Overview The computed tomography (CT) systems market size was $5.63 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Computed tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. This technique is used in patients with a high risk of colon cancer. CT is also performed for full-motion heart scans...
-
Product Insights
Likelihood of Approval Analysis for Hypertrophic Cardiomyopathy
Overview How likely is it that the drugs in Hypertrophic Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertrophic Cardiomyopathy Overview Hypertrophic cardiomyopathy (HCM) is a disease in which the...
-
Product Insights
Likelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Product Insights
Likelihood of Approval Analysis for Hypertension
Overview How likely is it that the drugs in Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertension Overview Hypertension, commonly known as high blood pressure, is a chronic medical...
-
Product Insights
Likelihood of Approval Analysis for Cardiomyopathy
Overview How likely is it that the drugs in Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiomyopathy Overview Cardiomyopathy a disease of the heart muscle, where the walls of...
-
Product Insights
Likelihood of Approval Analysis for Pulmonary Hypertension
Overview How likely is it that the drugs in Pulmonary Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Hypertension Overview Pulmonary hypertension (PH) is a rare condition marked by...
-
Product Insights
Likelihood of Approval Analysis for Atrial Fibrillation
Overview How likely is it that the drugs in Atrial Fibrillation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atrial Fibrillation Overview Atrial fibrillation is an irregular and often rapid heart...
-
Product Insights
Likelihood of Approval Analysis for Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that the drugs in Chronic Kidney Disease (Chronic Renal Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Kidney Disease (Chronic Renal Failure) Overview Chronic...
-
Product Insights
Likelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...
-
Product Insights
Likelihood of Approval Analysis for Dilated Cardiomyopathy
Overview How likely is it that the drugs in Dilated Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dilated Cardiomyopathy Overview Dilated cardiomyopathy (DCM) is a condition in which the...